Metallodrugs in cancer nanomedicine

Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation

Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197 · see citing works

<b>Hard and Soft Acids and Bases</b>

Pearson, R. G. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00905a001 · Cited by 10,475 · see citing works

Nanocarriers as an emerging platform for cancer therapy

Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710 · see citing works

Safety and activity of anti-PD-L1 antibody in patients with advanced cancer

Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945 · see citing works

Engineering precision nanoparticles for drug delivery

Mitchell, M. J., Billingsley, M. M., Haley, R. M., Wechsler, M. E., Peppas, N. A., & Langer, R. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0090-8 · Cited by 7,933 · see citing works

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Conroy, T., Desseigne, F., Ychou, M., Bouché, O., Guimbaud, R., Bécouarn, Y., Adenis, A., Raoul, J.-L., Gourgou-Bourgade, S., de la Fouchardière, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011923 · Cited by 7,810 · see citing works

Understanding biophysicochemical interactions at the nano–bio interface

Nel, A. E., Mädler, L., Velegol, D., Xia, T., Hoek, E. M. V., Somasundaran, P., Klaessig, F., Castranova, V., & Thompson, M. (2009) · Nature Materials · doi:10.1038/nmat2442 · Cited by 7,083 · see citing works

Principles of nanoparticle design for overcoming biological barriers to drug delivery

Blanco, E., Shen, H., & Ferrari, M. (2015) · Nature Biotechnology · doi:10.1038/nbt.3330 · Cited by 7,002 · see citing works

Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer

Gandhi, L., Rodríguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., De Angelis, F., Domine, M., Clingan, P., Hochmair, M. J., Powell, S. F., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801005 · Cited by 6,607 · see citing works

Stimuli-responsive nanocarriers for drug delivery

Mura, S., Nicolas, J., & Couvreur, P. (2013) · Nature Materials · doi:10.1038/nmat3776 · Cited by 6,289 · see citing works

Cancer nanomedicine: progress, challenges and opportunities

Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873 · see citing works

Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?

Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452 · see citing works

Analysis of nanoparticle delivery to tumours

Wilhelm, S., Tavares, A. J., Dai, Q., Ohta, S., Audet, J., Dvorak, H. F., & Chan, W. C. W. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.14 · Cited by 5,218 · see citing works

The Warburg Effect: How Does it Benefit Cancer Cells?

Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · see citing works

Liposomal drug delivery systems: From concept to clinical applications

Allen, T. M., & Cullis, P. R. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.037 · Cited by 4,839 · see citing works

Doxil® — The first FDA-approved nano-drug: Lessons learned

Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · see citing works

The resurgence of platinum-based cancer chemotherapy

Kèlland, L. R. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2167 · Cited by 4,733 · see citing works

Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer

Valle, J. W., Wasan, H. S., Palmer, D. H., Cunningham, D., Anthoney, A., Maraveyas, A., Madhusudan, S., Iveson, T. J., Hughes, S., Pereira, S. P., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908721 · Cited by 4,423 · see citing works

The metabolism of tumors in the body

Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416 · see citing works

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works

Cellular processing of platinum anticancer drugs

Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801 · see citing works

Liposome: classification, preparation, and applications

Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati‐Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,648 · see citing works

Otto Warburg's contributions to current concepts of cancer metabolism

Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427 · see citing works

Cisplatin: mode of cytotoxic action and molecular basis of resistance

Siddik, Z. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206933 · Cited by 3,335 · see citing works

Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release

Kamaly, N., Yameen, B., Wu, J., & Farokhzad, O. C. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00346 · Cited by 3,070 · see citing works

Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode

Rosenberg, B., Camp, L. V., & Krigas, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,052 · see citing works

Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology

Bertrand, N., Wu, J., Xu, X., Kamaly, N., & Farokhzad, O. C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.009 · Cited by 2,865 · see citing works

Molecular mechanisms of cisplatin resistance

Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760 · see citing works

Advances and Challenges of Liposome Assisted Drug Delivery

Sercombe, L., Veerati, T., Moheimani, F., Wu, S. Y., Sood, A. K., & Hua, S. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00286 · Cited by 2,672 · see citing works

Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer

Rose, P. G., Bundy, B. N., Watkins, E. B., Thigpen, J. T., Deppe, G., Maiman, M. A., Clarke‐Pearson, D. L., & Insalaco, S. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904153401502 · Cited by 2,662 · see citing works

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

Armstrong, D. K., Bundy, B. N., Wenzel, L. B., Huang, H. Q., Baergen, R. N., Lele, S., Copeland, L. J., Walker, J. L., & Burger, R. A. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052985 · Cited by 2,626 · see citing works

Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date

Bobo, D., Robinson, K. J., Islam, J., Thurecht, K. J., & Corrie, S. R. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1958-5 · Cited by 2,586 · see citing works

Reactive Oxygen Species (ROS)-Based Nanomedicine

Yang, B., Chen, Y., & Shi, J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00626 · Cited by 2,453 · see citing works

Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size

Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q., Murakami, M., Kimura, M., Terada, Y., Kano, M. R., Miyazono, K., Uesaka, M., et al. (2011) · Nature Nanotechnology · doi:10.1038/nnano.2011.166 · Cited by 2,429 · see citing works

Metal–Organic Framework (MOF)‐Based Drug/Cargo Delivery and Cancer Therapy

Wu, M., & Yang, Y. (2017) · Advanced Materials · doi:10.1002/adma.201606134 · Cited by 2,297 · see citing works

Progress and challenges towards targeted delivery of cancer therapeutics

Rosenblum, D., Joshi, N., Tao, W., Karp, J. M., & Peer, D. (2018) · Nature Communications · doi:10.1038/s41467-018-03705-y · Cited by 2,220 · see citing works

Role of target geometry in phagocytosis

Champion, J. A., & Mitragotri, S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600997103 · Cited by 2,082 · see citing works

Cancer Immunotherapy

Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051 · see citing works

A History of Cancer Chemotherapy

DeVita, V. T., & Chu, E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6611 · Cited by 1,973 · see citing works

New-Concept Chemotherapy by Nanoparticles of Biodegradable Polymers: Where Are We Now?

Feng, S.-S. (2006) · Nanomedicine · doi:10.2217/17435889.1.3.297 · Cited by 1,951 · see citing works

Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface

Salvati, A., Pitek, A. S., Monopoli, M. P., Prapainop, K., Bombelli, F. B., Hristov, D. R., Kelly, P. M., Åberg, C., Mahon, E., & Dawson, K. A. (2013) · Nature Nanotechnology · doi:10.1038/nnano.2012.237 · Cited by 1,912 · see citing works

Negative staining of phospholipids and their structural modification by surface-active agents as observed in the electron microscope

Bangham, A. D., & Horne, R. W. (1964) · Journal of Molecular Biology · doi:10.1016/s0022-2836(64)80115-7 · Cited by 1,810 · see citing works

Advances in Copper Complexes as Anticancer Agents

Santini, C., Pellei, M., Gandin, V., Porchia, M., Tisato, F., & Marzano, C. (2013) · Chemical Reviews · doi:10.1021/cr400135x · Cited by 1,795 · see citing works

Nanoparticles in the clinic: an update

Anselmo, A. C., & Mitragotri, S. (2019) · Bioengineering &amp; Translational Medicine · doi:10.1002/btm2.10143 · Cited by 1,766 · see citing works

The side effects of platinum-based chemotherapy drugs: a review for chemists

Oun, R., Moussa, Y. E., & Wheate, N. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,740 · see citing works

Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell lung cancer (IMpower130): a multicentre, randomised, open-label, phase 3 trial

West, H., McCleod, M., Hussein, M., Morabito, A., Rittmeyer, A., Conter, H. J., Kopp, H.-G., Daniel, D., McCune, S., Mekhail, T., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30167-6 · Cited by 1,662 · see citing works

The status of platinum anticancer drugs in the clinic and in clinical trials

Wheate, N., Walker, S., Craig, G. E., & Oun, R. (2010) · Dalton Transactions · doi:10.1039/c0dt00292e · Cited by 1,638 · see citing works

The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs

Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636 · see citing works

Mechanisms of Cisplatin Nephrotoxicity

Miller, R. P., Tadagavadi, R. K., Ramesh, G., & Reeves, W. B. (2010) · Toxins · doi:10.3390/toxins2112490 · Cited by 1,635 · see citing works

Chemistry of MRI Contrast Agents: Current Challenges and New Frontiers

Wahsner, J., Gale, E. M., Rodríguez‐Rodríguez, A., & Caravan, P. D. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00363 · Cited by 1,613 · see citing works

Freeze-drying of nanoparticles: Formulation, process and storage considerations

ABDELWAHED, W., DEGOBERT, G., STAINMESSE, S., & FESSI, H. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.017 · Cited by 1,611 · see citing works

Estimation of clinical trial success rates and related parameters

Wong, C. H., Siah, K. W., & Lo, A. W. (2019) · Biostatistics · doi:10.1093/biostatistics/kxx069 · Cited by 1,585 · see citing works

Postsynthetic Modifications of Iron-Carboxylate Nanoscale Metal−Organic Frameworks for Imaging and Drug Delivery

Taylor-Pashow, K. M. L., Rocca, J. D., Xie, Z., Tran, S., & Lin, W. (2009) · Journal of the American Chemical Society · doi:10.1021/ja906198y · Cited by 1,522 · see citing works

Transition Metal Complexes and Photodynamic Therapy from a Tumor-Centered Approach: Challenges, Opportunities, and Highlights from the Development of TLD1433

Monro, S. M. A., Colón, K. L., Yin, H., Roque, J. A., Konda, P., Gujar, S. A., Thummel, R. P., Lilge, L. D., Cameron, C. G., & McFarland, S. A. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00211 · Cited by 1,469 · see citing works

Toxicity of nanomaterials

Sharifi, S., Behzadi, S., Laurent, S., Laird Forrest, M., Stroeve, P., & Mahmoudi, M. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15188f · Cited by 1,460 · see citing works

Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiforme

Maier-Hauff, K., Ulrich, F., Nestler, D., Niehoff, H., Wust, P., Thiesen, B., Orawa, H., Budach, V., & Jordan, A. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0389-0 · Cited by 1,447 · see citing works

Direct Cellular Responses to Platinum-Induced DNA Damage

Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,393 · see citing works

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

Lammers, T., Kiessling, F., Hennink, W. E., & Storm, G. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.063 · Cited by 1,324 · see citing works

Connecting copper and cancer: from transition metal signalling to metalloplasia

Ge, E. J., Bush, A. I., Casini, A., Cobine, P. A., Cross, J. R., DeNicola, G. M., Dou, Q. P., Franz, K. J., Gohil, V. M., Gupta, S. K., et al. (2021) · Nature reviews. Cancer · doi:10.1038/s41568-021-00417-2 · Cited by 1,316 · see citing works

Metallodrugs in Medicinal Inorganic Chemistry

Mjos, K. D., & Orvig, C. (2014) · Chemical Reviews · doi:10.1021/cr400460s · Cited by 1,311 · see citing works

Design, functionalization strategies and biomedical applications of targeted biodegradable/biocompatible polymer-based nanocarriers for drug delivery

Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270 · see citing works

Tumor targeting via EPR: Strategies to enhance patient responses

Golombek, S. K., May, J.-N., Theek, B., Appold, L., Drude, N., Kiessling, F., & Lammers, T. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.07.007 · Cited by 1,262 · see citing works

Smart cancer nanomedicine

van der Meel, R., Sulheim, E., Shi, Y., Kiessling, F. M., Mulder, W. J. M., & Lammers, T. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0567-y · Cited by 1,251 · see citing works

Imaging and drug delivery using theranostic nanoparticles

Janib, S. M., Moses, A. S., & MacKay, J. A. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.004 · Cited by 1,249 · see citing works

Polymers for the sustained release of proteins and other macromolecules

LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182 · see citing works

Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications

Dadfar, S. M., Roemhild, K., Drude, N. I., von Stillfried, S., Knüchel, R., Kiessling, F., & Lammers, T. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.005 · Cited by 1,181 · see citing works

Toward a full understanding of the EPR effect in primary and metastatic tumors as well as issues related to its heterogeneity

Maeda, H. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.002 · Cited by 1,179 · see citing works

Postsynthetic modification of metal–organic frameworks—a progress report

Tanabe, K. K., & Cohen, S. M. (2010) · Chemical Society Reviews · doi:10.1039/c0cs00031k · Cited by 1,179 · see citing works

Immunogenic death of colon cancer cells treated with oxaliplatin

Tesnière, A., Schlemmer, F., Boige, V., Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apétoh, L., Barault, L., et al. (2009) · Oncogene · doi:10.1038/onc.2009.356 · Cited by 1,177 · see citing works

Antibody Targeting of Long-Circulating Lipidic Nanoparticles Does Not Increase Tumor Localization but Does Increase Internalization in Animal Models

Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,129 · see citing works

A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer

du Bois, A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg036 · Cited by 1,114 · see citing works

Protein drug stability: a formulation challenge

Frøkjær, S., & Otzen, D. E. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1695 · Cited by 1,102 · see citing works

Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization

Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,089 · see citing works

Encyclopedia of inorganic chemistry

(2006) · Choice Reviews Online · doi:10.5860/choice.43-5015 · Cited by 1,081 · see citing works

Doxorubicin Cardiomyopathy

Chatterjee, K., Zhang, J., Honbo, N. Y., & Karliner, J. S. (2009) · Cardiology · doi:10.1159/000265166 · Cited by 1,074 · see citing works

Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer

Loupakis, F., Cremolini, C., Masi, G., Lonardi, S., Zagonel, V., Salvatore, L., Cortesi, E., Tomasello, G., Ronzoni, M., Spadi, R., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1403108 · Cited by 1,062 · see citing works

Wilson's disease and other neurological copper disorders

Bandmann, O., Weiss, K. H., & Kaler, S. G. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70190-5 · Cited by 1,040 · see citing works

Matching chelators to radiometals for radiopharmaceuticals

Price, E. W., & Orvig, C. (2013) · Chemical Society Reviews · doi:10.1039/c3cs60304k · Cited by 1,020 · see citing works

The development of anticancer ruthenium( ii ) complexes: from single molecule compounds to nanomaterials

Zeng, L., Gupta, P., Chen, Y., Wang, E., Ji, L., Chao, H., & Chen, Z. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00195a · Cited by 1,020 · see citing works

Nanomedicine Applications of Hybrid Nanomaterials Built from Metal–Ligand Coordination Bonds: Nanoscale Metal–Organic Frameworks and Nanoscale Coordination Polymers

He, C., Liu, D., & Lin, W. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00125 · Cited by 1,006 · see citing works

Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA–PEG nanoparticles

Dhar, S., Gu, F., Langer, R., Farokhzad, O. C., & Lippard, S. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809154105 · Cited by 994 · see citing works

Application of Metal Coordination Chemistry To Explore and Manipulate Cell Biology

Haas, K. L., & Franz, K. J. (2009) · Chemical Reviews · doi:10.1021/cr900134a · Cited by 987 · see citing works

Interaction of Gold Nanoparticles with Common Human Blood Proteins

Lacerda, S. H. D. P., Park, J. J., Meuse, C. W., et al. (2009) · ACS Nano · doi:10.1021/nn9011187 · Cited by 981 · see citing works

Radiopharmaceutical therapy in cancer: clinical advances and challenges

Sgouros, G., Bodei, L., McDevitt, M. R., & Nedrow, J. R. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0073-9 · Cited by 980 · see citing works

The rediscovery of platinum-based cancer therapy

Rottenberg, S., Disler, C., & Perego, P. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-00308-y · Cited by 977 · see citing works

Immunogenic Chemotherapy Sensitizes Tumors to Checkpoint Blockade Therapy

Pfirschke, C., Engblom, C., Rickelt, S., Cortez‐Retamozo, V., Garris, C., Pucci, F., Yamazaki, T., Poirier-Colame, V., Newton, A., Redouane, Y., et al. (2016) · Immunity · doi:10.1016/j.immuni.2015.11.024 · Cited by 944 · see citing works

Structural aspects of platinum anticancer drug interactions with DNA

Sherman, S. E., & Lippard, S. J. (1987) · Chemical Reviews · doi:10.1021/cr00081a013 · Cited by 934 · see citing works

Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease

Wadas, T. J., Wong, E. H., Weisman, G. R., & Anderson, C. J. (2010) · Chemical Reviews · doi:10.1021/cr900325h · Cited by 926 · see citing works

Hard and soft acids and bases—The evolution of a chemical concept

Pearson, R. G. (1990) · Coordination Chemistry Reviews · doi:10.1016/0010-8545(90)85016-l · Cited by 886 · see citing works

Nanoscale metal-organic frameworks for the co-delivery of cisplatin and pooled siRNAs to enhance therapeutic efficacy in drug-resistant ovarian cancer cells

He, C., Lu, K., Liu, D., & Lin, W. (2014) · Journal of the American Chemical Society · doi:10.1021/ja4098862 · Cited by 885 · see citing works

Advances in Biomaterials for Drug Delivery

Fenton, O. S., Olafson, K. N., Pillai, P. S., Mitchell, M. J., & Langer, R. (2018) · Advanced Materials · doi:10.1002/adma.201705328 · Cited by 869 · see citing works

Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics

Mi, P. (2020) · Theranostics · doi:10.7150/thno.38069 · Cited by 843 · see citing works

Post-synthetic modification of covalent organic frameworks

Segura, J. L., Royuela, S., & Ramos, M. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00978c · Cited by 833 · see citing works

On the medicinal chemistry of gold complexes as anticancer drugs

Ott, I. (2009) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2009.02.019 · Cited by 828 · see citing works

Targeting copper in cancer therapy: ‘Copper That Cancer’

Denoyer, D., Masaldan, S., Fontaine, S. L., & Cater, M. A. (2015) · Metallomics · doi:10.1039/c5mt00149h · Cited by 807 · see citing works

Systems biology of cisplatin resistance: past, present and future

Galluzzi, L., Vitale, I., Michels, J., Brenner, C., Szabadkai, G., Harel-Bellan, A., Castedo, M., & Kroemer, G. (2014) · Cell Death &amp; Disease · doi:10.1038/cddis.2013.428 · Cited by 782 · see citing works

Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population

Adams, P. C., Reboussin, D. M., Barton, J. C., McLaren, C. E., Eckfeldt, J. H., McLaren, G. D., Dawkins, F. W., Acton, R. T., Harris, E. L., Gordeuk, V. R., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa041534 · Cited by 770 · see citing works

Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches

Galanski, M. S., Jakupec, M. A., & Keppler, B. K. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867054637626 · Cited by 724 · see citing works

Phase I and Pharmacokinetic Studies of CYT-6091, a Novel PEGylated Colloidal Gold-rhTNF Nanomedicine

Libutti, S. K., Paciotti, G. F., Byrnes, A. A., Alexander, H. R., Gannon, W. E., Walker, M., Seidel, G., Yuldasheva, N., & Tamarkin, L. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-0978 · Cited by 717 · see citing works

Metallodrugs are unique: opportunities and challenges of discovery and development

Anthony, E. J., Bolitho, E. M., Bridgewater, H. E., Carter, O. W. L., Donnelly, J. M., Imberti, C., Lant, E. C., Lermyte, F., Needham, R. J., Palau, M., et al. (2020) · Chemical Science · doi:10.1039/d0sc04082g · Cited by 710 · see citing works

Polymeric nanoparticles for targeted drug delivery system for cancer therapy

Masood, F. (2015) · Materials Science and Engineering C · doi:10.1016/j.msec.2015.11.067 · Cited by 702 · see citing works

Cellular toxicity of inorganic nanoparticles: Common aspects and guidelines for improved nanotoxicity evaluation

Soenen, S. J., Rivera-Gil, P., Montenegro, J., et al. (2011) · Nano Today · doi:10.1016/j.nantod.2011.08.001 · Cited by 701 · see citing works

Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges

Martin, J. D., Cabral, H., Stylianopoulos, T., & Jain, R. K. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0308-z · Cited by 688 · see citing works

Natural products in cancer chemotherapy: past, present and future

Mann, J. (2002) · Nature reviews. Cancer · doi:10.1038/nrc723 · Cited by 685 · see citing works

Enhanced Cisplatin Chemotherapy by Iron Oxide Nanocarrier-Mediated Generation of Highly Toxic Reactive Oxygen Species

Ma, P., Xiao, H., Chang, Y., Liu, J., Cheng, Z., Song, H., Zhang, X., Li, C., Wang, J., Gu, Z., et al. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b04269 · Cited by 651 · see citing works

Stimuli-Responsive Therapeutic Metallodrugs

Wang, X., Wang, X., Jin, S., Nafees, M., & Guo, Z. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 651 · see citing works

Toward Multi-Targeted Platinum and Ruthenium Drugs—A New Paradigm in Cancer Drug Treatment Regimens?

Kenny, R. G., & Marmion, C. J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00271 · Cited by 636 · see citing works

Cytotoxicity and Immunological Response of Gold and Silver Nanoparticles of Different Sizes

Yen, H., Hsu, S., & Tsai, C. (2009) · Small · doi:10.1002/smll.200900126 · Cited by 635 · see citing works

Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update

Hesketh, P. J., Kris, M. G., Basch, E., Bohlke, K., Barbour, S. Y., Clark-Snow, R. A., Danso, M. A., Dennis, K. E. B., Dupuis, L. L., Dusetzina, S. B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.74.4789 · Cited by 634 · see citing works

Synthetic Methods for the Preparation of Platinum Anticancer Complexes

Wilson, J. J., & Lippard, S. J. (2013) · Chemical Reviews · doi:10.1021/cr4004314 · Cited by 631 · see citing works

Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth

Kim, S. E., Zhang, L., Ma, K., Riegman, M., Chen, F., Ingold, I., Conrad, M., Turker, M. Z., Gao, M., Jiang, X., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.164 · Cited by 622 · see citing works

Inorganic nanoparticles for cancer imaging and therapy

Huang, H., Barua, S., Sharma, G., Dey, S. K., & Rege, K. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.06.004 · Cited by 620 · see citing works

Interactions of Antitumor Metallodrugs with Serum Proteins: Advances in Characterization Using Modern Analytical Methodology

Timerbaev, A. R., Hartinger, C. G., Aleksenko, S. S., & Keppler, B. K. (2006) · Chemical Reviews · doi:10.1021/cr040704h · Cited by 615 · see citing works

Using coordination chemistry to design new medicines

Ronconi, L., & Sadler, P. J. (2006) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2006.11.017 · Cited by 608 · see citing works

Survey of Clinical Translation of Cancer Nanomedicines—Lessons Learned from Successes and Failures

He, H., Liu, L., Morin, E. E., Liu, M., & Schwendeman, A. A. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00228 · Cited by 592 · see citing works

The regulation of nanomaterials and nanomedicines for clinical application: current and future perspectives

Foulkes, R., Man, E., Thind, J., Yeung, S., Joy, A., & Hoskins, C. (2020) · Biomaterials Science · doi:10.1039/d0bm00558d · Cited by 585 · see citing works

Organoiridium Complexes: Anticancer Agents and Catalysts

Liu, Z., & Sadler, P. J. (2014) · Accounts of Chemical Research · doi:10.1021/ar400266c · Cited by 576 · see citing works

Polymeric micelles in cancer therapy: State of the art

Ghosh, B., & Biswas, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.016 · Cited by 553 · see citing works

Role of iron in carcinogenesis: cancer as a ferrotoxic disease

Toyokuni, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2008.01001.x · Cited by 552 · see citing works

NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial

Bonvalot, S., Rutkowski, P. L., Thariat, J., Carrère, S., Ducassou, A., Sunyach, M., Ágoston, P., Hong, A., Mervoyer, A., Rastrelli, M., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30326-2 · Cited by 541 · see citing works

Cancer nanomedicines: So many papers and so few drugs!

Venditto, V. J., & Szoka, F. C. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.038 · Cited by 538 · see citing works

The Discovery and Development of Cisplatin

Alderden, R. A., Hall, M. D., & Hambley, T. W. (2006) · Journal of Chemical Education · doi:10.1021/ed083p728 · Cited by 537 · see citing works

Redox activation of metal-based prodrugs as a strategy for drug delivery

Graf, N., & Lippard, S. J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.01.007 · Cited by 522 · see citing works

(Intra)Cellular Stability of Inorganic Nanoparticles: Effects on Cytotoxicity, Particle Functionality, and Biomedical Applications

Soenen, S. J., Parak, W. J., Rejman, J., & Manshian, B. B. (2015) · Chemical Reviews · doi:10.1021/cr400714j · Cited by 520 · see citing works

Metal-based anticancer chemotherapeutic agents

Nafees, M., & Guo, Z. (2014) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2014.02.003 · Cited by 516 · see citing works

Approaching tumour therapy beyond platinum drugs

Bergamo, A., Gaiddon, C., Schellens, J. H. M., Beijnen, J. H., & Sava, G. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.09.030 · Cited by 515 · see citing works

Amino Terminal Cu(II)- and Ni(II)-Binding (ATCUN) Motif of Proteins and Peptides: Metal Binding, DNA Cleavage, and Other Properties

Harford, C., & Sarkar, B. (1997) · Accounts of Chemical Research · doi:10.1021/ar9501535 · Cited by 514 · see citing works

Targeted delivery of a cisplatin prodrug for safer and more effective prostate cancer therapy in vivo

Dhar, S., Kolishetti, N., Lippard, S. J., & Farokhzad, O. C. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011379108 · Cited by 513 · see citing works

Polyvalent Oligonucleotide Gold Nanoparticle Conjugates as Delivery Vehicles for Platinum(IV) Warheads

Dhar, S., Daniel, W. L., Giljohann, D. A., et al. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9071282 · Cited by 510 · see citing works

Non-platinum group metal antitumor agents. History, current status, and perspectives

KOEPF‐MAIER, P., & KOEPF, H. (1987) · Chemical Reviews · doi:10.1021/cr00081a012 · Cited by 509 · see citing works

“Combo” nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy

Kemp, J. A., Shim, M. S., Heo, C. Y., & Kwon, Y. J. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.10.019 · Cited by 508 · see citing works

Nanoparticle Characterization: What to Measure?

Modena, M. M., Rühle, B., Burg, T. P., & Wuttke, S. (2019) · Advanced Materials · doi:10.1002/adma.201901556 · Cited by 505 · see citing works

Ruthenium-based chemotherapeutics: are they ready for prime time?

Antonarakis, E. S., & Emadi, A. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1293-1 · Cited by 489 · see citing works

Radioactive Main Group and Rare Earth Metals for Imaging and Therapy

Kostelnik, T. I., & Orvig, C. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00294 · Cited by 482 · see citing works

Ru(II) Compounds: Next-Generation Anticancer Metallotherapeutics?

Thota, S., Rodrigues, D. A., Crans, D. C., & Barreiro, E. J. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01689 · Cited by 476 · see citing works

Beitrag zur Konstitution anorganischer Verbindungen

Werner, A. (1893) · Zeitschrift für anorganische und allgemeine Chemie · doi:10.1002/zaac.18930030136 · Cited by 474 · see citing works

Photodynamic Therapy Mediated by Nontoxic Core–Shell Nanoparticles Synergizes with Immune Checkpoint Blockade To Elicit Antitumor Immunity and Antimetastatic Effect on Breast Cancer

Duan, X., Chan, C., Guo, N., Han, W., Weichselbaum, R. R., & Lin, W. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b09538 · Cited by 458 · see citing works

Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update

Ramalho, J., Semelka, R. C., Ramalho, M., et al. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4615 · Cited by 456 · see citing works

Classification of Metal-Based Drugs according to Their Mechanisms of Action

Boros, E., Dyson, P. J., & Gasser, G. (2019) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 451 · see citing works

Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers

Zhao, Z., Ukidve, A., Krishnan, V., & Mitragotri, S. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.01.002 · Cited by 449 · see citing works

Obstacles and opportunities in a forward vision for cancer nanomedicine

de Lázaro, I., & Mooney, D. J. (2021) · Nature Materials · doi:10.1038/s41563-021-01047-7 · Cited by 442 · see citing works

Tumour‐associated macrophages act as a slow‐release reservoir of nano‐therapeutic Pt(IV) pro‐drug

Miller, M. A., Zheng, Y.-R., Gadde, S., Pfirschke, C., Zope, H., Engblom, C., Kohler, R. H., Iwamoto, Y., Yang, K. S., Askevold, B., et al. (2015) · Nature Communications · doi:10.1038/ncomms9692 · Cited by 441 · see citing works

Pt(IV) Prodrugs Designed to Bind Non-Covalently to Human Serum Albumin for Drug Delivery

Zheng, Y., Suntharalingam, K., Johnstone, T. C., Yoo, H., Wei, L., Brooks, J. G., & Lippard, S. J. (2014) · Journal of the American Chemical Society · doi:10.1021/ja5038269 · Cited by 441 · see citing works

Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines

Thomsen, H. S., Morcos, S. K., Almèn, T., Bellin, M., Bertolotto, M., Bongartz, G. M., Clémеnt, O., Leander, P., Heinz‐Peer, G., Reimer, P., et al. (2012) · European Radiology · doi:10.1007/s00330-012-2597-9 · Cited by 440 · see citing works

Mouse Models for Cancer Immunotherapy Research

Olson, B. M., Li, Y., Lin, Y. S., Liu, E. T., & Patnaik, A. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0044 · Cited by 439 · see citing works

The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs

Nagayasu, A., Uchiyama, K., & Kiwada, H. (1999) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(99)00041-1 · Cited by 438 · see citing works

Cisplatin-incorporating polymeric micelles (NC-6004) can reduce nephrotoxicity and neurotoxicity of cisplatin in rats

Uchino, H., Matsumura, Y., Negishi, T., Koizumi, F., Hayashi, T., Honda, T., Nishiyama, N., Kataoka, K., Naito, S., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602772 · Cited by 430 · see citing works

Structure–activity relationships for ruthenium and osmium anticancer agents – towards clinical development

Meier, S. M., Gerner, C., Berger, W., Hartinger, C. G., & Keppler, B. K. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00332c · Cited by 426 · see citing works

25 Years of Reticular Chemistry

Freund, R., Canossa, S., Cohen, S. M., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202101644 · Cited by 419 · see citing works

Metal based drugs: from serendipity to design

Fricker, S. P. (2007) · Dalton Transactions · doi:10.1039/b705551j · Cited by 414 · see citing works

Key Concepts of Clinical Trials: A Narrative Review

Umscheid, C. A., Margolis, D. J., & Grossman, C. E. (2011) · Postgraduate Medicine · doi:10.3810/pgm.2011.09.2475 · Cited by 411 · see citing works

Primovist, Eovist: What to expect?

BEERS, B. E. V., Pastor, C. M., & Hussain, H. K. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.01.031 · Cited by 408 · see citing works

Cancer drug delivery in the nano era: An overview and perspectives

Li, Z., Tan, S., Li, S., Shen, Q., & Wang, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5718 · Cited by 407 · see citing works

Challenges in nanomedicine clinical translation

Metselaar, J. M., & Lammers, T. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00740-5 · Cited by 405 · see citing works

Nanocarriers for delivery of platinum anticancer drugs

Oberoi, H. S., Nukolova, N. V., Kabanov, A. V., & Bronich, T. K. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.014 · Cited by 397 · see citing works

Inorganic Nanoparticles in Cancer Therapy

Bhattacharyya, S., Kudgus, R. A., Bhattacharya, R., & Mukherjee, P. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0318-0 · Cited by 395 · see citing works

Combine and conquer: challenges for targeted therapy combinations in early phase trials

Lopez, J. S., & Banerji, U. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.96 · Cited by 394 · see citing works

Curing metastatic testicular cancer

Einhorn, L. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072067999 · Cited by 392 · see citing works

A Phase I clinical study of cisplatin-incorporated polymeric micelles (NC-6004) in patients with solid tumours

Plummer, R., Wilson, R. H., Calvert, H., Boddy, A. V., Griffin, M., Sludden, J., Tilby, M. J., Eatock, M., Pearson, D. G., Ottley, C. J., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.6 · Cited by 390 · see citing works

Anti-cancer palladium complexes: a focus on PdX 2 L 2 , palladacycles and related complexes

Kapdi, A. R., & Fairlamb, I. J. S. (2014) · Chemical Society Reviews · doi:10.1039/c4cs00063c · Cited by 379 · see citing works

Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes

Hall, M. D., Telma, K. A., Chang, K.-E., Lee, T. D., Madigan, J. P., Lloyd, J. R., Goldlust, I. S., Hoeschele, J. D., & Gottesman, M. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0247 · Cited by 377 · see citing works

What do we know about the reduction of Pt(IV) pro-drugs?

Wexselblatt, E., & Gibson, D. (2012) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2012.06.013 · Cited by 372 · see citing works

Delivery of drugs, proteins, and nucleic acids using inorganic nanoparticles

Luther, D. C., Huang, R., Jeon, T., Zhang, X., Lee, Y.-W., Nagaraj, H., & Rotello, V. M. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.020 · Cited by 372 · see citing works

Nanomedicines for Reactive Oxygen Species Mediated Approach: An Emerging Paradigm for Cancer Treatment

Kwon, S., Ko, H., You, D. G., Kataoka, K., & Park, J. H. (2019) · Accounts of Chemical Research · doi:10.1021/acs.accounts.9b00136 · Cited by 370 · see citing works

Enhanced Tumor-Specific Disulfiram Chemotherapy by In Situ Cu 2+ Chelation-Initiated Nontoxicity-to-Toxicity Transition

Wu, W., Yu, L., Jiang, Q., Huo, M., Lin, H., Wang, L., Chen, Y., & Shi, J. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b03503 · Cited by 359 · see citing works

Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors

Centanni, M., Moes, D. J. A. R., Trocóniz, I. F., Ciccolini, J., & van Hasselt, J. G. C. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00748-2 · Cited by 358 · see citing works

Introduction: The History of Arsenic Trioxide in Cancer Therapy

Antman, K. H. (2001) · The Oncologist · doi:10.1634/theoncologist.6-suppl_2-1 · Cited by 356 · see citing works

Metal Drugs and the Anticancer Immune Response

Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355 · see citing works

Ligand Substitution Reactions at Inorganic Centers

Richens, D. T. (2005) · Chemical Reviews · doi:10.1021/cr030705u · Cited by 350 · see citing works

The Chemistry of Reticular Framework Nanoparticles: MOF, ZIF, and COF Materials

Ploetz, E., Engelke, H., Lächelt, U., & Wuttke, S. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201909062 · Cited by 348 · see citing works

The Potent Oxidant Anticancer Activity of Organoiridium Catalysts

Liu, Z., Romero‐Canelón, I., Qamar, B., Hearn, J. M., Habtemariam, A., Barry, N. P. E., Pizarro, A. M., Clarkson, G. J., & Sadler, P. J. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201311161 · Cited by 346 · see citing works

Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice

Lesterhuis, W. J., Punt, C. J. A., Hato, S. V., Eleveld-Trancikova, D., Jansen, B., Nierkens, S., Schreibelt, G., de Boer, A. J., van Herpen, C. M. L., Kaanders, J. H. A. M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci43656 · Cited by 340 · see citing works

Where metal ions bind in proteins.

Yamashita, M. M., Wesson, L., Eisenman, G., & Eisenberg, D. S. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5648 · Cited by 330 · see citing works

Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies

Ho, G., Woodward, N. E., & Coward, J. I. G. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.03.014 · Cited by 326 · see citing works

Determination of Drug Release Kinetics from Nanoparticles: Overcoming Pitfalls of the Dynamic Dialysis Method

Modi, S., & Anderson, B. D. (2013) · Molecular Pharmaceutics · doi:10.1021/mp400154a · Cited by 314 · see citing works

Metal-based anticancer drugs: From a past anchored in platinum chemistry to a post-genomic future of diverse chemistry and biology

Hannon, M. J. (2007) · Pure and Applied Chemistry · doi:10.1351/pac200779122243 · Cited by 313 · see citing works

Chelation: Harnessing and Enhancing Heavy Metal Detoxification—A Review

Sears, M. (2013) · The Scientific World JOURNAL · doi:10.1155/2013/219840 · Cited by 308 · see citing works

Tumor-Targeted Cascade Nanoreactor Based on Metal–Organic Frameworks for Synergistic Ferroptosis–Starvation Anticancer Therapy

Wan, X., Song, L., Pan, W., Hui, Z., Li, N., & Tang, B. (2020) · ACS Nano · doi:10.1021/acsnano.9b07789 · Cited by 307 · see citing works

Concepts and models in bioinorganic chemistry

(2007) · Choice Reviews Online · doi:10.5860/choice.44-5065 · Cited by 305 · see citing works

Why develop photoactivated chemotherapy?

Bonnet, S. A. (2018) · Dalton Transactions · doi:10.1039/c8dt01585f · Cited by 300 · see citing works

Radioactive Transition Metals for Imaging and Therapy

Boros, E., & Packard, A. B. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00281 · Cited by 300 · see citing works

Technetium and Gallium Derived Radiopharmaceuticals: Comparing and Contrasting the Chemistry of Two Important Radiometals for the Molecular Imaging Era

Bartholomä, M. D., Louie, A. S., Valliant, J. F., & Zubieta, J. A. (2010) · Chemical Reviews · doi:10.1021/cr1000755 · Cited by 298 · see citing works

Coordinating ability of anions and solvents towards transition metals and lanthanides

Díaz‐Torres, R., & Álvarez, S. (2011) · Dalton Transactions · doi:10.1039/c1dt11000d · Cited by 294 · see citing works

Controlling the Stealth Effect of Nanocarriers through Understanding the Protein Corona

Schöttler, S., Landfester, K., & Mailänder, V. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201602233 · Cited by 292 · see citing works

Oxygen and Pt(II) self-generating conjugate for synergistic photo-chemo therapy of hypoxic tumor

Xu, S., Zhu, X., Zhang, C., Huang, W., Zhou, Y., & Yan, D. (2018) · Nature Communications · doi:10.1038/s41467-018-04318-1 · Cited by 292 · see citing works

Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of ¹⁷⁷ Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer

Violet, J., Sandhu, S., Iravani, A., Ferdinandus, J., Thang, S.-P., Kong, G., Kumar, A. R., Akhurst, T., Pattison, D., Beaulieu, A., et al. (2020) · Journal of Nuclear Medicine · doi:10.2967/jnumed.119.236414 · Cited by 292 · see citing works

Metal ion recognition in ligands with negatively charged oxygen donor groups. Complexation of iron(III), gallium(III), indium(III), aluminum(III), and other highly charged metal ions

Evers, A., Hancock, R. D., Martell, A. E., & Motekaitis, R. J. (1989) · Inorganic Chemistry · doi:10.1021/ic00310a035 · Cited by 291 · see citing works

Meta-analysis of clinical and preclinical studies comparing the anticancer efficacy of liposomal versus conventional non-liposomal doxorubicin

Petersen, G. H., Alzghari, S. K., Chee, W., Sankari, S. S., & La-Beck, N. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.028 · Cited by 291 · see citing works

Platinum( iv ) anticancer prodrugs – hypotheses and facts

Gibson, D. (2016) · Dalton Transactions · doi:10.1039/c6dt01414c · Cited by 286 · see citing works

Rationally designed ruthenium complexes for 1- and 2-photon photodynamic therapy

Karges, J., Kuang, S., Maschietto, F., Blacque, O., Ciofini, I., Chao, H., & Gasser, G. (2020) · Nature Communications · doi:10.1038/s41467-020-16993-0 · Cited by 286 · see citing works

Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine

Pearce, A. K., & O’Reilly, R. K. (2019) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.9b00456 · Cited by 280 · see citing works

Pleated Sheets and Turns of -Peptides with Proteinogenic Side Chains

Seebàch, D., Abele, S., Gademann, K., & Jaun, B. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19990601)38:11 · Cited by 268 · see citing works

Factors affecting stabilities of chelate, macrocyclic and macrobicyclic complexes in solution

Martell, A. E., Hancock, R. D., & Motekaitis, R. J. (1994) · Coordination Chemistry Reviews · doi:10.1016/0010-8545(94)80056-1 · Cited by 265 · see citing works

Multifunctional Efficiency: Extending the Concept of Atom Economy to Functional Nanomaterials

Freund, R., Lächelt, U., Gruber, T., Rühle, B., & Wuttke, S. (2018) · ACS Nano · doi:10.1021/acsnano.8b00932 · Cited by 263 · see citing works

Engineered nanoparticles for biomolecular imaging

Mahmoudi, M., Serpooshan, V., & Laurent, S. (2011) · Nanoscale · doi:10.1039/c1nr10326a · Cited by 262 · see citing works

Facts and evidences on the lyophilization of polymeric nanoparticles for drug delivery

Fonte, P., Reis, S., & Sarmento, B. F. C. C. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.01.034 · Cited by 262 · see citing works

How much do clinical trials cost?

Martin, L., Hutchens, M., Hawkins, C., & Radnov, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.70 · Cited by 262 · see citing works

Multidrug resistance: Physiological principles and nanomedical solutions

Kunjachan, S., Rychlik, B., Storm, G., Kiessling, F. M., & Lammers, T. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.018 · Cited by 259 · see citing works

Immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy to eradicate colorectal tumors

Duan, X., Chan, C., Han, W., Guo, N., Weichselbaum, R. R., & Lin, W. (2019) · Nature Communications · doi:10.1038/s41467-019-09221-x · Cited by 256 · see citing works

The Prodrug Platin‐A: Simultaneous Release of Cisplatin and Aspirin

Pathak, R., Marrache, S., Choi, J. H., Berding, T. B., & Dhar, S. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201308899 · Cited by 255 · see citing works

Radiopharmaceuticals: navigating the frontier of precision medicine and therapeutic innovation

Dhoundiyal, S., Srivastava, S., Kumar, S., Singh, G., Ashique, S., Pal, R., Mishra, N., & Taghizadeh-Hesary, F. (2024) · European Journal of Medical Research · doi:10.1186/s40001-023-01627-0 · Cited by 144 · see citing works

Glutathione-responsive and -exhausting metal nanomedicines for robust synergistic cancer therapy

Liu, P., Hao, L., Liu, M., & Hu, S. (2023) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2023.1161472 · Cited by 58 · see citing works

The emergence of nanocarriers in the management of diseases and disorders

Khulbe, P., Singh, D., Aman, A., et al. (2023) · Community Acquired Infection · doi:10.54844/cai.2022.0139 · Cited by 5 · see citing works

Oxaliplatin─Based Chemotherapy の腹膜播種を伴うStage IV 大腸癌に対する効果

幡野哲, & ほか (2013) · 癌と化学療法

Ligand decorated biodegradable nanomedicine in the treatment of cancer

Ahmad, E., Ali, A., Fatima, M. T., Nimisha, Apurva, A., Kumar, A., Sumi, M. P., Sattar, R. S. A., Mahajan, B., & Saluja, S. S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105544 · Cited by 33 · see citing works

Editorial: Nanomedicine-Based Drug Delivery Systems: Recent Developments and Future Prospects

Shakeel, F. (2023) · Molecules · doi:10.3390/molecules28104138 · Cited by 12 · see citing works

Nanoparticle-mediated Drug Delivery Systems (DDS) in the Central Nervous System

Zhang, G., Chen, L., Guo, X., et al. (2016) · Current Organic Chemistry · doi:10.2174/1385272820666161017170325 · Cited by 6 · see citing works